Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Althae is a medical nutrition company dedicated to supporting individuals undergoing GLP-1 weight loss treatments. The company's primary offering, "The Companion," is a daily nutritional supplement formulated to address the specific physiological challenges of rapid weight loss, such as muscle mass preservation and gastrointestinal health. By focusing on nutrient gaps and the muscle-to-fat loss ratio, Althae aims to ensure that patients achieve healthy, sustainable results while using pharmaceutical interventions. The business was established by healthcare industry veterans to fill a critical void in the current obesity care continuum. Their products are designed based on clinical data regarding the side effects of GLP-1 receptor agonists like semaglutide and tirzepatide. Althae operates as a direct-to-consumer and provider-recommended brand, integrating medical-grade nutrition with modern weight management protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Althae Nutrition.